bpc-157 human clinical trial osteoarthritis BPC-157: What the Science Actually Says BPC-157 and Healing Peptides: Hype

In that study, the authors used young adult (8-10 weeks old) male C57BL/6 mice and performed a dosage screen (from 0.1% to 0.6%) by examining the demyelination in the corpus callosum of cerebral white matter, a brain region where the extent of demyelination can be scored more easily and consistently than the previously described superior cerebellar peduncles with LFB-PAS staining (Skripuletz et al., 2011)

13 Another study, comparing oral and sublingual administration of a complex of B12, folate and vitamin B6 also found no significant differences in effect on homocysteine between the two modes of administration

Summary Considering the wide spectrum of action of the BPC-157 peptide, therapy with this peptide can be confidently recommended primarily to professional athletes but also to people engaging in physical activity as well as those who do not, because our musculoskeletal system unfortunately undergoes damage spontaneously during the performance of basic life activities

Chloramphenicol can blunt the hematologic response to B12 therapy